ENT Updates, cilt.6, sa.3, ss.105-109, 2016 (ESCI, TRDizin)
Objective: To evaluate the antitumor effect of cetuximab as a single agent for the treatment of oral cavity cancers and to clarify the dose-dependent growth inhibitory effect in oral cavity squamous cell carcinoma cell line (OCSCCCL).